跳至主要内容
临床试验/NL-OMON50116
NL-OMON50116撤回不适用

The use of nasal airway stent (Nastent R) in patients with sleep-disordered breathing (SDB) including snoring and/or obstructive sleep apnea (OSA). - NASTENT trial

astent, inc0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • AHI < 20 per hour of sleep
  • Complaints of socially disturbing snoring by partner
  • Capable of giving informed consent

排除标准

  • - Craniofacial deformities
  • - Acute nasal trauma, fracture (during past 3 months)
  • - Nasal valve collapse, synechiae and septal perforation, recurrent epistaxis,
  • recent nasopharyngeal surgery, chronic rhinosinusitis with or without polyposis
  • - Cerebrospinal fluid leaks
  • - History of past or current psychiatric disorders (psychotic illness, major
  • depression, or acute anxiety attacks as mentioned by the patient), intellectual
  • disability, memory disorders, seizure disorders, neuromuscular disorders,
  • cardiovascular diseases, coagulopathies (thrombocytopenia< 100/µl), lower
  • respiratory tract disorders.
  • - Pregnancy or willing to become pregnant
  • - Excessive alcohol or drug use (>20 alcohol units/week or any use of hard
  • - Sleep medication use

研究者

发起方
astent, inc

相似试验